Literature DB >> 7322684

Utility of M-mode echocardiography for early identification of infants with persistent pulmonary hypertension of the newborn.

L M Valdes-Cruz, G G Dudell, A Ferrara.   

Abstract

The clinical syndrome of persistent pulmonary hypertension of the newborn (PPHN) still carries high mortality in spite of improved neonatal care. The purpose of this prospective study was to assess the utility of M-mode echocardiography for the early identification of infants with PPHN prior to clinical deterioration. Echocardiograms of 51 infants who needed fractional inspiratory oxygen (FIO2) greater than or equal to 0.25 to maintain adequate PaO2 within 36 hours of life were compared to those of 115 healthy full-term and preterm newborns. Of the 51 infants, ten had elevated systolic time interval ratios of both ventricles simultaneously (ventricular pre-ejection period to ventricular ejection time [RPEP/RVET greater than or equal to 0.50, LPEP/LVET greater than 0.38]). All of these newborns had PPHN that was manifest clinically by 11 to 30 hours of age. The echocardiographic findings preceded clinical deterioration by at least one to five hours in all cases. The other 41 infants had clinical courses consistent with uncomplicated pulmonary disease. These data indicate that systolic time interval ratios, although not accurate measures of pulmonary arterial pressure and/or pulmonary vascular resistance, permit early identification of infants with PPHN and separation from others with uncomplicated pulmonary disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7322684

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  7 in total

1.  A comprehensive study of clinical biomarkers, use of inotropic medications and fluid resuscitation in newborns with persistent pulmonary hypertension.

Authors:  Janardhan Mydam; Marwan Zidan; Nitin Shashikant Chouthai
Journal:  Pediatr Cardiol       Date:  2014-08-09       Impact factor: 1.655

2.  Heart rate and systolic time intervals in healthy newborn infants: longitudinal study.

Authors:  W Lindner; C Döhlemann; K Schneider; H Versmold
Journal:  Pediatr Cardiol       Date:  1985       Impact factor: 1.655

3.  Use of myocardial performance index in pediatric patients with idiopathic pulmonary arterial hypertension.

Authors:  Karrie L Dyer; Linda B Pauliks; Bibhuti Das; Robin Shandas; Dunbar Ivy; Elizabeth M Shaffer; Lilliam M Valdes-Cruz
Journal:  J Am Soc Echocardiogr       Date:  2006-01       Impact factor: 5.251

4.  The pulmonic valve echogram in the assessment of pulmonary hypertension in children.

Authors:  J Marin-Garcia; J H Moller; D M Mirvis
Journal:  Pediatr Cardiol       Date:  1983 Jul-Sep       Impact factor: 1.655

5.  Persistent pulmonary arterial hypertension of the newborn.

Authors:  A Narang; O N Bhakoo; P M Nair; V Bhandari
Journal:  Indian J Pediatr       Date:  1992 Nov-Dec       Impact factor: 1.967

6.  Correlation of echocardiographic markers and therapy in persistent pulmonary hypertension of the newborn.

Authors:  Amy L Peterson; Sara Deatsman; Michele A Frommelt; Kathy Mussatto; Peter C Frommelt
Journal:  Pediatr Cardiol       Date:  2008-09-09       Impact factor: 1.655

7.  Clinical and echocardiographic evidence suggesting afterload reduction as a mechanism of action of tolazoline in neonatal hypoxemia.

Authors:  G G Sandor; A J Macnab; F A Akesode; V J Ebelt; M R Pendray; W Y Ling; M W Patterson; M A Tipple
Journal:  Pediatr Cardiol       Date:  1984 Apr-Jun       Impact factor: 1.655

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.